HedgeChatter

  • Home /
  • Tag Archives

ABBV

The Biotech Stocks JMP Is Watching – Merck & Company, Inc …

Related MRKSunTrust’s Latest Comments On MerckMorgan Stanley’s Major Pharma Q1 PreviewMerck, NewLink Ebola Vaccine Enters Third Phase III Study – Analyst Blog(Zacks)Related Why Johnson & Johnson’s Strong Pharmaceutical Business Is A ConcernBenzinga’s Top UpgradesNew drug trial results positive(Investor’s Business Daily)In a report published Thursday, JMP Securities analysts expressed their views on Biotechnology stocks after the EASL abstracts were made available […]

April 9, 2015 ByMonica Gerson , , , , , , , , Comments Off on The Biotech Stocks JMP Is Watching – Merck & Company, Inc … read more

ABBVIE INC. Files SEC form 10-Q, Quarterly Report

moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here to view […]

May 9, 2014 Bystocknews , Comments Off on ABBVIE INC. Files SEC form 10-Q, Quarterly Report read more

3 Stocks Raising The Drugs Industry Higher

moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here to view […]

May 7, 2014 Bystocknews , Comments Off on 3 Stocks Raising The Drugs Industry Higher read more

Finding Yield In Health Care

moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here to view […]

May 5, 2014 Bystocknews , Comments Off on Finding Yield In Health Care read more

Actavis sues U.S. drug regulator over generic Celebrex

[Reuters] – Actavis Plc said on Monday it has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Teva Pharmaceutical Industries Ltd to sell a generic version of Pfizer Inc’s blockbuster painkiller Celebrex. moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is […]

April 28, 2014 Bystocknews , Comments Off on Actavis sues U.S. drug regulator over generic Celebrex read more

Is Johnson & Johnson’s Dividend Unbeatable?

moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here to view […]

April 16, 2014 Bystocknews , Comments Off on Is Johnson & Johnson’s Dividend Unbeatable? read more